## ITW: Illinois Tool Works Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -0.2% below STRENGTH zone (4.0-10.0%); PEG 3.46 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($243.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Does Doverâ€™s Data Center Pivot And Raised Guidance Reshape The Bull Case For DOV?**
- Source: Simply Wall Street | 20251223T000823 | Neutral | Relevance: 63%
- Jim Cramer highlighted Dover Corporation's strong quarterly results and its strategic pivot towards higher-growth markets like data centers, aerospace, and clean energy. This shift, coupled with raised full-year earnings guidance, aims to reposition Dover's portfolio for better margins and more resilient demand. The article discusses how these changes could impact Dover's investment narrative, while also acknowledging the ongoing risk from its more cyclical industrial segments.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Goldman Sachs | $230 | $258 | -11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Goldman Sachs | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.11M) |
| Sells | 3 ($0.37M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.8% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.1%)
- Briar Hall Managemen: 8.9% (0.0%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 7.2% (-3.6%)
- State Street Corpora: 4.3% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.5x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.46 signals overvaluation risk, limited margin of safety. Forward P/E 22.3x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 16%, margin 19%). Analyst sentiment negative (1 target cuts vs 0 raises).

| Metric | Value |
|--------|-------|
| Market Cap | $73.3B |
| Beta | 1.15 |
| 52W Range | $214.66 - $278.13 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.46 |
| Forward P/E | 22.3 |
| Current P/E | 24.1 |
| YoY Growth | 8.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.8% to -0.2% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 52. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.23% (CS: 44) | Neutral |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.003x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $251.52
- **Stop Loss:** $243.24 (3.3% risk)
- **Target:** $259.80 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 108
- **Position Value:** $27,164.16
- **Portfolio %:** 27.16%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-04 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.70 | $2.81 | +4.0% |
| 2025Q2 | $2.57 | $2.58 | +0.5% |
| 2025Q1 | $2.35 | $2.38 | +1.1% |
| 2024Q4 | $2.49 | $2.54 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*